Eton Pharmaceuticals Inc. (ETON) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Eton Pharmaceuticals Inc. (ETON)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

13.28

-0.14 (-1.04%)

At close: Jan 15, 2025, 9:33 AM

undefined% (undefined)

Bid	13.16
Market Cap	353.71M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-0.21
PE Ratio (ttm)	-63.24
Forward PE	n/a
Analyst	Strong Buy

Ask	13.66
Volume	4,841
Avg. Volume (20D)	227,237
Open	13.55
Previous Close	13.42
Day's Range	13.28 - 13.55
52-Week Range	3.03 - 15.00
Beta	undefined

About ETON

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; and Rezip...

[Show more]

Industry Biotechnology

Sector Healthcare

IPO Date Nov 13, 2018

Employees 30

Stock Exchange NASDAQ

Ticker Symbol ETON

Website https://www.etonpharma.com

Analyst Forecast

According to 3 analyst ratings, the average rating for ETON stock is "Strong Buy." The 12-month stock price forecast is $18, which is an increase of 35.54% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Eton Pharmaceuticals Inc. is scheduled to release its earnings on Mar 13, 2025, during market hours.
Analysts project revenue of $10.55M, reflecting a 44.26% YoY growth and earnings per share of 0, making a -100.00% decrease YoY.

Why Price Moved

2 months ago · Source

+15.59%

Eton Pharmaceuticals shares are trading higher aft... Unlock content with Pro Subscription

3 months ago · Source

+16.33%

Eton Pharmaceuticals shares are trading higher after the company announced they entered into an asset purchase agreement to acquire Increlex from Ipsen.

News

1 month ago · zacks.com

What Makes Eton Pharmaceuticals (ETON) a Good Fit for 'Trend Investing'

Eton Pharmaceuticals (ETON) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed t...

2 months ago · seekingalpha.com

Eton Pharmaceuticals, Inc. (ETON) Q3 2024 Earnings Call Transcript

Eton Pharmaceuticals, Inc. (NASDAQ:ETON ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants David Krempa – Chief Business Officer Sean Brynjelsen – Chief Executive Off...